In 2023, the mortality rate due to liver malignant neoplasms in Germany for females stood at 6.8 deaths per 100,000 women. The forecast for the period from 2024 to 2028 shows a gradual increase in mortality rates. The rate is projected to rise from 6.9 in 2024 to 7.1 by 2028, with slight year-on-year increases noted particularly in 2027 and 2028 at approximately 1.4% from the previous year. The compound annual growth rate (CAGR) over these five years is expected to be moderate, indicating a consistent marginal rise in mortality rates.
Future trends to watch for include advances in medical technology and treatments, changes in healthcare policies, and potential increases in awareness and prevention techniques. These could significantly impact mortality rates, possibly reducing them more than currently forecasted. Monitoring the effectiveness of interventions and early detection programs will be crucial in influencing future forecasts positively.
